Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

June 8, 2020

Study Completion Date

June 8, 2020

Conditions
Sickle Cell Anemia
Interventions
DRUG

Hydroxyurea

Given orally once daily.

Trial Locations (4)

30322

Emory University/Children's Health Care of Atlanta, Atlanta

38105

St. Jude Children's Research Hospital, Memphis

39216

University of Mississippi Medical Center, Jackson

75390-9063

University of Texas Southwestern Medical Center at Dallas, Dallas

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT03020615 - Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies | Biotech Hunter | Biotech Hunter